Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST000346)

(Analysis AN000561)

Metabolite	Structure	F1	F2	F3	F4
SM (d34:1)	ME119167	0.12	0.08	7.68	0.13
TG (52:2)	ME119177	0.05	0.15	7.69	0.12
TG (52:3)	ME119178	0.04	0.13	7.69	0.15
LPC (16:0)	ME119096	0.02	0.07	8.21	0.02
TG (52:4)	ME119179	0.03	0.09	7.94	0.10
LPC (18:0)	ME119097	0.05	0.13	7.94	0.04
LPC (18:1)	ME119098	0.04	0.11	8.01	0.05
TG (52:1)	ME119176	0.09	0.84	5.87	0.13
PC (35:4)	ME119120	0.35	0.71	5.14	0.28
PC (p-40:6) or PC (o-40:7) A	ME119155	0.41	0.60	5.31	0.26
PC (36:4) B	ME119126	0.34	0.67	5.27	0.29
PC (38:5) A	ME119135	0.33	0.64	5.31	0.31
SM (d42:1)	ME119173	0.30	0.53	5.77	0.26
PC (40:7)	ME119142	0.33	0.56	5.60	0.27
PC (p-34:2) or PC (o-34:3)	ME119150	0.43	0.50	5.57	0.24
SM (d36:1)	ME119169	0.17	0.27	6.92	0.20
PC (38:3)	ME119132	0.14	0.29	7.03	0.16
SM (d41:1)	ME119172	0.14	0.29	7.02	0.17
TG (56:7)	ME119180	0.10	0.21	7.13	0.23
SM (d42:3)	ME119175	0.12	0.27	7.16	0.14
PC (40:6) B	ME119141	0.14	0.25	7.19	0.14
SM (d34:2)	ME119168	0.16	0.24	7.16	0.14
PC (40:4)	ME119138	0.18	0.32	6.82	0.18
SM (d40:1)	ME119171	0.18	0.33	6.75	0.19
CE (20:4)	ME119094	0.09	0.42	6.58	0.26
PC (38:6) A	ME119137	0.21	0.38	6.58	0.18
SM (d38:1)	ME119170	0.20	0.38	6.54	0.19
SM (d42:2)	ME119174	0.19	0.33	6.67	0.21
SM (d32:1)	ME119163	0.22	0.35	6.64	0.17
SM (d33:1)	ME119164	0.19	0.37	6.66	0.17
PC (p-36:3) or PC (o-36:4)	ME119151	0.15	0.41	6.70	0.16
PC (p-38:3) or PC (o-38:4)	ME119153	0.15	0.43	6.63	0.18
PC (40:5) B	ME119140	0.24	0.43	6.36	0.18
PC (p-38:4) or PC (o-38:5) A	ME119154	0.20	0.43	6.43	0.19
PC (p-34:1) or PC (o-34:2) A	ME119148	0.25	0.45	6.24	0.20
CE (18:1)	ME119091	0.23	0.37	6.27	0.30
PC (40:5) A	ME119139	0.22	0.39	6.34	0.26
PC (p-36:4) or PC (o-36:5)	ME119152	0.19	0.44	6.30	0.25
PC (38:4) A	ME119133	0.26	0.47	6.02	0.26
CE (18:2)	ME119092	0.24	0.39	6.04	0.36
CE (18:3)	ME119093	0.24	0.35	6.15	0.34
SM (d34:0)	ME119165	0.25	0.34	6.14	0.35
Acylcarnitine C16:0	ME119089	0.65	1.58	1.75	0.47
Acylcarnitine C18:1	ME119090	0.58	1.65	1.81	0.45
PC (36:4) C	ME119127	0.79	1.25	1.65	0.70
PC (36:5) A	ME119128	0.89	1.39	1.71	0.44
PC (16:0/9:0(CHO))	ME119099	1.02	1.07	1.93	0.54
Cholesterol	ME119095	0.79	1.13	1.96	0.70
PC (35:1)	ME119116	0.76	1.33	1.91	0.54
PC (p-40:7) or PC (o-40:8)	ME119156	0.73	1.60	1.42	0.51
PC (34:3)	ME119113	1.03	1.42	1.34	0.42
PC (o-32:0)	ME119144	0.88	1.62	1.05	0.47
PC (32:2)	ME119106	0.94	1.45	1.22	0.52
PC (34:4)	ME119114	0.82	1.58	1.23	0.50
PE (36:1)	ME119158	0.98	1.50	0.54	0.70
PC (p-32:0) or PC (o-32:1)	ME119146	1.04	1.55	0.79	0.50
PE (34:2)	ME119157	0.91	1.52	0.93	0.60
PC (33:1)	ME119109	0.93	1.59	0.83	0.55
PC (o-34:0)	ME119145	0.87	1.62	0.76	0.61
PC (32:0)	ME119104	0.95	1.58	0.07	0.85
PC (28:0)	ME119100	0.97	1.76	0.10	0.64
PC (34:0)	ME119111	0.96	1.73	0.16	0.64
PC (30:0)	ME119101	1.07	1.68	0.04	0.63
PC (32:3)	ME119107	1.05	1.73	0.05	0.60
PC (30:1)	ME119102	1.06	1.73	0.15	0.55
PC (32:1)	ME119105	1.07	1.67	0.13	0.61
PC (31:0)	ME119103	1.07	1.83	0.04	0.48
PC (33:0)	ME119108	0.96	1.93	0.04	0.49
1_CUDA (pos) iSTD iSTD	ME119074	1.02	0.77	1.04	1.19
1_Sphingosine (d17:1) iSTD	ME119086	1.09	1.02	0.55	1.07
1_Ceramide C17 iSTD	ME119072	1.04	1.06	0.60	1.06
1_CE (22:1) iSTD	ME119069	1.05	1.02	0.65	1.07
1_MG (17:0/0:0/0:0) iSTD	ME119082	1.05	1.04	0.69	1.04
1_Cholesterol d7 iSTD	ME119073	1.13	0.93	0.31	1.22
1_DG (12:0/12:0/0:0) iSTD	ME119076	1.07	1.06	0.45	1.08
1_DG (18:1/2:0/0:0) iSTD	ME119078	1.07	1.06	0.47	1.09
1_LPC (17:0) iSTD	ME119079	1.04	1.07	0.44	1.11
1_LPE (17:1) iSTD	ME119080	1.05	1.09	0.42	1.10
1_PC (25:0) iSTD	ME119083	1.09	1.08	0.34	1.09
1_SM (d35:1) iSTD	ME119085	1.04	1.12	0.36	1.10
1_PE (17:0/17:0) iSTD	ME119084	1.01	1.03	0.38	1.21
1_TG (17:0/17:1/17:0)-d5 iSTD	ME119088	1.10	0.98	0.40	1.16
PC (35:2)	ME119118	0.71	1.31	2.29	0.47
PC (36:4) A	ME119125	0.76	1.23	2.43	0.43
PC (36:3) A	ME119123	0.79	1.13	2.34	0.54
PC (p-34:0) or PC (o-34:1)	ME119147	0.77	1.17	2.36	0.52
PC (36:1)	ME119121	0.66	1.04	3.07	0.47
PC (36:3) B	ME119124	0.66	1.04	3.22	0.40
PC (40:8)	ME119143	0.74	1.19	2.70	0.39
PE (p-36:4) or PE (o-36:5)	ME119160	0.60	1.05	2.81	0.63
PE (p-36:2) or PE (o-36:3)	ME119159	0.70	1.08	2.87	0.48
PC (34:2)	ME119112	0.69	1.08	2.77	0.51
PC (35:3)	ME119119	0.73	1.07	2.74	0.50
PC (33:2)	ME119110	0.68	0.99	3.51	0.33
PC (37:4)	ME119130	0.51	1.09	3.56	0.38
PE (p-38:4) or PE (o-38:5)	ME119161	0.49	0.99	3.64	0.46
PC (38:5) B	ME119136	0.41	0.79	4.80	0.28
PE (p-38:5) or PE (o-38:6)	ME119162	0.50	0.74	4.05	0.54
PC (36:5) B	ME119129	0.46	0.92	4.28	0.30
PC (36:2)	ME119122	0.52	0.81	4.26	0.37
PC (38:4) B	ME119134	0.52	0.87	4.26	0.32
PC (38:2)	ME119131	0.46	0.78	4.46	0.37
PC (p-34:1) or PC (o-34:2) B	ME119149	0.41	0.95	4.42	0.27

Factors:

F1	Condition:Mild Asthma
F2	Condition:No Asthma
F3	Condition:Quality Control
F4	Condition:Severe Asthma

Data matrix